Interventional Oncology Devices | Market Insights | Asia Pacific (Supplemental) | 2023
Despite the short term challenges posed by the COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2031 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will continue to remain a challenge.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Asia Pacific region from 2019 to 2031.
